Clinical Trial Update: ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a ctDNA-guided CURB strategy for oligo-progressive metastatic non-small cell lung cancer in patients on tyrosine kinase inhibi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Oligoprogressive Metastatic Disease

Snippet

Sponsor: University Health Network, Toronto | Conditions: Metastatic NSCLC - Non-Small Cell Lung Cancer, OligoProgressive Metastatic Disease | Phase 2 | Status: NOT_YET_RECRUITING